Fennec Pharmaceuticals Inc. Common Stock — Quarterly Financial Statements (NASDAQ:FENC) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Market Capitalization 236.78 M
Employee 32
Founded 1996
CEO N/A
Website www.fennecpharma.com
Headquarter British Columbia, Canada
FIGI BBG000DTH814
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

236.78 M Market capitalization

Price to earnings ratio

-49.26

Price to sales ratio

6.67

Dividends per share

—

Dividend yield %

—

뉴스

Certara, Inc. (CERT) Q4 Earnings Lag Estimates

Apellis Pharmaceuticals, Inc. (APLS) Surpasses Q4 Earnings and Revenue Estimates

Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC)

City of Hope to study PEDMARK for hearing protection in testicular cancer

Fennec’s pediatric hearing protection drug shows positive results in Japan

Pedmark Delivers In Japan Study — Less Hearing Loss, Same Cancer-Fighting Power - Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals repays all outstanding convertible notes

Fennec Pharmaceuticals raises $5 million in non-brokered offering

Fennec Pharmaceuticals raises $40.25 million through public offering

Fennec Pharmaceuticals plans $5 million share offering to existing investors

Fennec Pharmaceuticals prices $35 million public offering

Adherex Technologies Inc. (FENC) Reports Q3 Loss, Tops Revenue Estimates